Literature DB >> 7841858

Opiate withdrawal.

M Farrell1.   

Abstract

Opiate withdrawal is one of the longest studied and most well described withdrawal syndromes. Opiate withdrawal has been described as akin to a moderate to severe flu-like illness. Opiate withdrawal is appropriately described as subjectively severe but objectively mild. This paper describes the mechanisms of opiate dependence and opiate withdrawal and reviews the available instruments for the measurement of withdrawal. The time course of assisted and unassisted withdrawal is described and the range of options for the management of assisted withdrawal are described. This review concludes that the most effective and least time- and resource-consuming approach to opiate withdrawal will substantially contribute to the overall social management of opiate dependence.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7841858     DOI： 10.1111/j.1360-0443.1994.tb03745.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


  31 in total

1.  Cocaine and opioid use during pregnancy: prevalence and management.

Authors:  Chaya G Bhuvaneswar; Grace Chang; Lucy A Epstein; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 2.  Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.

Authors:  Linda Gowing; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 3.  Use of opioids for treatment of osteoporotic pain.

Authors:  Renato Vellucci; Rocco Domenico Mediati; Giovanna Ballerini
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

Review 4.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

Review 5.  Update on the clinical use of buprenorphine: in opioid-related disorders.

Authors:  Simon Ducharme; Ronald Fraser; Kathryn Gill
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

Review 6.  Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence.

Authors:  Kelly E Dunn; Andrew S Huhn; Cecilia L Bergeria; Cassandra D Gipson; Elise M Weerts
Journal:  J Pharmacol Exp Ther       Date:  2019-08-07       Impact factor: 4.030

Review 7.  An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure.

Authors:  Steven D Stockton; Lakshmi A Devi
Journal:  Neuropsychopharmacology       Date:  2013-09-18       Impact factor: 7.853

Review 8.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

Review 9.  Alpha₂-adrenergic agonists for the management of opioid withdrawal.

Authors:  Linda Gowing; Michael Farrell; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2016-05-03

Review 10.  Opioids and the treatment of chronic pain: controversies, current status, and future directions.

Authors:  Andrew Rosenblum; Lisa A Marsch; Herman Joseph; Russell K Portenoy
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.